Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Stem cell transplant offers some patients with blood cancers and blood disorders the possibility of a cure, and others a longer period of disease-free survival. Founded in 1972, our Adult Stem Cell Transplantation Program is one of the largest and most experienced in the world.
Experience Matters Our program performs approximately 500 transplants each year and has performed more than 9,700 transplants in the program’s history. This includes more than 5,000 allogeneic transplants and more than 4,700 autologous transplants. This experience makes a difference for our patients. Our patients' outcomes regularly exceed expected outcomes as established by the Center for International Blood and Marrow Transplant Research, which reports and analyzes outcomes for recipients of allogeneic hematopoietic stem cell transplant. In the latest report (2018), only 7% of centers achieved this outcome level.
Our program performs approximately 500 transplants each year and has performed more than 9,700 transplants in the program’s history. This includes more than 5,000 allogeneic transplants and more than 4,700 autologous transplants. This experience makes a difference for our patients.
Our patients' outcomes regularly exceed expected outcomes as established by the Center for International Blood and Marrow Transplant Research, which reports and analyzes outcomes for recipients of allogeneic hematopoietic stem cell transplant. In the latest report (2018), only 7% of centers achieved this outcome level.
We are experienced in stem cell transplant for a variety of hematologic malignancies, bone marrow failure syndromes, and rare and congenital blood disorders. This includes:
We perform both autologous and allogeneic stem cell transplants.
For allogeneic patients (i.e., those requiring donor stem cells), we offer:
Reduced-intensity transplants in which lower doses of chemotherapy are used have been a major factor in extending stem cell transplants for older adults up into their 70s. Our program has transplanted more than 4,300 patients over 55 years. Our Older Adult Hematologic Malignancies Program provides dedicated support for older patients.
From exceptional medical care to support with housing and other logistics, we offer many services to international patients:
Learn more about international referrals and services.
New Patient Appointments 877-442-3324
Looking for the Pediatric Stem Cell Transplant Center? The Stem Cell Transplant Center at Dana-Farber/Boston Children's Cancer and Blood Disorders Center is one of the world's largest, most experienced pediatric stem cell transplant centers.
The Stem Cell Transplant Center at Dana-Farber/Boston Children's Cancer and Blood Disorders Center is one of the world's largest, most experienced pediatric stem cell transplant centers.
Learn about our Cellular Therapies Program Learn about donating stem cells/bone marrow
Clinical Trials Questions?
877-DF-TRIAL (877-338-7425)
Joseph Antin, MD, presents "The Basics of Stem Cell Transplantation" at Cancer Survivorship 101 on June 8, 2019, an event produced by Survivor Journeys™ (survivorjourneys.org).
As a new Dana-Farber patient, find answers to questions about your first visit: what to bring, how to find us, where to park, and how to prepare.
We offer a wide range of services, from financial planning to creative arts to spiritual counsel, to support our patients through their cancer experiences.